Atlas Therapeutics Corp. ATTH
–
ATTH traded two-and-a-half times its ten day average volume on Wednesday, as the stock continued to make higher lows; quite the positive sign. The stock managed to close at its high of day, logging a modest gain of 13% on the day.
–
Pertaining to the chart, the MACD appears to be kissing, and ready for the impending cross that we pointed out yesterday, so we think there is a fair chance to see ATTH finish the week strong.
–
One of the reasons why we like Atlas, is the employment of Dr. Carlon Colker, the inventor of the company’s flagship product, MYO-T12. Dr. Colker has quite a resume` beyond MYO-T12, including treatment and advisory of some of MMA’s top fighters, and a lead role in R&D for such health supplements as Metabolife, Ripped Fuel, and Xenadrine.
–
He has also authored several books, and still serves as an attending physician at world renowned medical center Beth Isreal in NY, as well as Greenwich Hospital in Connecticut.
–
According to Dr. Colker: “Of all the supplements I’ve developed, MYO-T12 is by far, the most effective anti-aging and fitness enhancement product you can buy.”
–
For those of you that may have missed the short ATTH pdf report we linked yesterday, why not take a look today, it is a good way to begin learning more about this ecxiting company.
